131 related articles for article (PubMed ID: 21864204)
1. Avoidant coping in panic disorder: a yohimbine biological challenge study.
Kaplan JS; Arnkoff DB; Glass CR; Tinsley R; Geraci M; Hernandez E; Luckenbaugh D; Drevets WC; Carlson PJ
Anxiety Stress Coping; 2012 Jul; 25(4):425-42. PubMed ID: 21864204
[TBL] [Abstract][Full Text] [Related]
2. Does coping predict CO2-induced panic in patients with panic disorder?
Schmidt NB; Meade Eggleston A; Trakowski JH; Smith JD
Behav Res Ther; 2005 Oct; 43(10):1311-9. PubMed ID: 16086982
[TBL] [Abstract][Full Text] [Related]
3. Avoidance-oriented coping as a predictor of panic-related distress: a test using biological challenge.
Spira AP; Zvolensky MJ; Eifert GH; Feldner MT
J Anxiety Disord; 2004; 18(3):309-23. PubMed ID: 15125979
[TBL] [Abstract][Full Text] [Related]
4. (Don't) panic in the scanner! How panic patients with agoraphobia experience a functional magnetic resonance imaging session.
Lueken U; Muehlhan M; Wittchen HU; Kellermann T; Reinhardt I; Konrad C; Lang T; Wittmann A; Ströhle A; Gerlach AL; Ewert A; Kircher T
Eur Neuropsychopharmacol; 2011 Jul; 21(7):516-25. PubMed ID: 21269812
[TBL] [Abstract][Full Text] [Related]
5. Panic disorder and social anxiety disorder subtypes in a caffeine challenge test.
Nardi AE; Lopes FL; Freire RC; Veras AB; Nascimento I; Valença AM; de-Melo-Neto VL; Soares-Filho GL; King AL; Araújo DM; Mezzasalma MA; Rassi A; Zin WA
Psychiatry Res; 2009 Sep; 169(2):149-53. PubMed ID: 19698996
[TBL] [Abstract][Full Text] [Related]
6. Comparison of gastrointestinal symptoms and psychological factors of functional dyspepsia to peptic ulcer or panic disorder patients.
Tominaga K; Higuchi K; Iketani T; Ochi M; Kadouchi K; Tanigawa T; Shiba M; Watanabe T; Fujiwara Y; Oshitani N; Nagata T; Kiriike N; Arakawa T
Inflammopharmacology; 2007 Apr; 15(2):84-9. PubMed ID: 17450448
[TBL] [Abstract][Full Text] [Related]
7. Effect of nicotine on 35% CO2-induced anxiety: A study in healthy volunteers.
Cosci F; Abrams K; Schruers KR; Rickelt J; Griez EJ
Nicotine Tob Res; 2006 Aug; 8(4):511-7. PubMed ID: 16920648
[TBL] [Abstract][Full Text] [Related]
8. Anxiogenic effects of Sumatriptan in panic disorder: a double-blind, placebo-controlled study.
Amital D; Fostick L; Sasson Y; Kindler S; Amital H; Zohar J
Eur Neuropsychopharmacol; 2005 May; 15(3):279-82. PubMed ID: 15820416
[TBL] [Abstract][Full Text] [Related]
9. Caffeine challenge in patients with panic disorder: baseline differences between those who panic and those who do not.
Masdrakis VG; Papakostas YG; Vaidakis N; Papageorgiou C; Pehlivanidis A
Depress Anxiety; 2008; 25(9):E72-9. PubMed ID: 17427182
[TBL] [Abstract][Full Text] [Related]
10. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease: a preliminary study of yohimbine challenge in patients with anxiety.
Richard IH; Szegethy E; Lichter D; Schiffer RB; Kurlan R
Clin Neuropharmacol; 1999; 22(3):172-5. PubMed ID: 10367182
[TBL] [Abstract][Full Text] [Related]
12. The role of anxiety sensitivity and lack of emotional approach coping in depressive symptom severity among a non-clinical sample of uncued panickers.
Tull MT; Gratz KL; Lacroce DM
Cogn Behav Ther; 2006; 35(2):74-87. PubMed ID: 16754263
[TBL] [Abstract][Full Text] [Related]
13. Effects of 7.5% CO2 challenge in generalized anxiety disorder.
Seddon K; Morris K; Bailey J; Potokar J; Rich A; Wilson S; Bettica P; Nutt DJ
J Psychopharmacol; 2011 Jan; 25(1):43-51. PubMed ID: 20233897
[TBL] [Abstract][Full Text] [Related]
14. Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls.
Gurguis GN; Vitton BJ; Uhde TW
Psychiatry Res; 1997 Jun; 71(1):27-39. PubMed ID: 9247979
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder.
Otto MW; Tolin DF; Simon NM; Pearlson GD; Basden S; Meunier SA; Hofmann SG; Eisenmenger K; Krystal JH; Pollack MH
Biol Psychiatry; 2010 Feb; 67(4):365-70. PubMed ID: 19811776
[TBL] [Abstract][Full Text] [Related]
16. Caffeine challenge test in panic disorder and depression with panic attacks.
Nardi AE; Lopes FL; Valença AM; Freire RC; Veras AB; de-Melo-Neto VL; Nascimento I; King AL; Mezzasalma MA; Soares-Filho GL; Zin WA
Compr Psychiatry; 2007; 48(3):257-63. PubMed ID: 17445520
[TBL] [Abstract][Full Text] [Related]
17. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
Pols H; Verburg K; Hauzer R; Meijer J; Griez E
Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
[TBL] [Abstract][Full Text] [Related]
18. Cigarette smoking and 35% CO(2) induced panic in panic disorder patients.
Knuts IJ; Cosci F; Esquivel G; Goossens L; van Duinen M; Bareman M; Overbeek T; Griez EJ; Schruers KR
J Affect Disord; 2010 Jul; 124(1-2):215-8. PubMed ID: 19896718
[TBL] [Abstract][Full Text] [Related]
19. The structure of lifetime panic-agoraphobic spectrum.
Rucci P; Miniati M; Oppo A; Mula M; Calugi S; Frank E; Shear MK; Mauri M; Pini S; Cassano GB
J Psychiatr Res; 2009 Jan; 43(4):366-79. PubMed ID: 18499126
[TBL] [Abstract][Full Text] [Related]
20. Somatic symptoms and physiologic responses in generalized anxiety disorder and panic disorder: an ambulatory monitor study.
Hoehn-Saric R; McLeod DR; Funderburk F; Kowalski P
Arch Gen Psychiatry; 2004 Sep; 61(9):913-21. PubMed ID: 15351770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
